title: Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy.
abstract: Large-scale assays, such as microarrays, next-generation sequencing and various "omics" technologies, have explored multiple aspects of the immune response following virus infection, often from a public health perspective. Yet a lack of similar data exists for monitoring immune engagement during oncolytic virus immunotherapy (OVIT) in the cancer setting. Tracking immune signatures at the tumour site can create a snapshot or longitudinally analyse immune cell activation, infiltration and functionality within global populations or individual cells. Mapping immune changes over the course of oncolytic biotherapy-from initial infection to tumour stabilisation/regression through to long-term cure or escape/relapse-has the potential to generate important therapeutic insights around virus-host interactions. Further, correlating such immune signatures with specific tumour outcomes has significant value for guiding the development of novel oncolytic virus immunotherapy strategies. Here, we provide insights for OVIT from large-scale analyses of immune populations in the infection, vaccination and immunotherapy setting. We analyse several approaches to manipulating immune engagement during OVIT. We further explore immunocentric changes in the tumour tissue following immunotherapy, and compile several immune signatures of therapeutic success. Ultimately, we highlight clinically relevant large-scale approaches with the potential to strengthen future oncolytic strategies to optimally engage the immune system.
authors: Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada. stephanies@arc.cheo.ca.
authors: Stephanie L
authors: SL
authors: Swift
authors: Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada. david@stojdllab.ca.|Department of Biology, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1N 6N5, Canada. david@stojdllab.ca.|Department of Pediatrics, University of Ottawa, Ottawa, ON K1N 6N5, Canada. david@stojdllab.ca.
authors: David F
authors: DF
authors: Stojdl
mesh_terms: D000818:Animals; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D050130:Oncolytic Virotherapy / Q000639:trends; D050504:Oncolytic Viruses / Q000235:genetics / Q000502:physiology*
keywords: immune; immunology; immunotherapy; large-scale; oncolytic; screen; virus